Home NDC 70752-151 POTASSIUM CHLORIDE
Product NDC 70752-151
11-digit product format 707520151
Labeler code 70752
Product ID 70752-151_3eb39560-d293-4af3-84b5-d2090b6b406c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name POTASSIUM CHLORIDE
Dosage form SOLUTION
Route ORAL
Labeler QUAGEN PHARMACEUTICALS LLC
Application ANDA215716
Marketing category ANDA
Marketing start 2021-12-16
Substance POTASSIUM CHLORIDE
Active strength 40 meq/15mL
Pharmacologic classes Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215716-001 POTASSIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA 2025-12-22 A215716-002 POTASSIUM CHLORIDE POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA 2025-12-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A215716-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA 2025-12-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215716-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA 2025-12-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215716-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA 2025-12-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215716-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA 2025-12-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215716-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA 2025-12-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215716-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA 2025-12-22 011fe1cb6892…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215716-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA 2025-12-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215716-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA 2025-12-22 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base POTASSIUM CHLORIDE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength POTASSIUM CHLORIDE 40 meq/15mL
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70752-151-12 70752015112 473 mL in 1 BOTTLE, PLASTIC (70752-151-12) 473 ml 2026-10-01 No No Current